A 5 to 10 beat per minute increase that a 35-year-old barely notices might cause fatigue, exercise intolerance, or shortness of breath in a 65-year-old
Rybelsus is an oral option for managing diabetes
doi: 10.1152/ajpgi.00251.2007 50 ZhaoHZhuHLinZLinGLvG
125,130 In 2022, tirzepatide was approved by the FDA for the treatment of T2DM in the United States
If you experience side effects or need further guidance, Pure Med Spas team is readily available to assist
Monitor for side effects (e.g., injection site irritation, unexpected hormonal changes), keep detailed logs of doses, timing, and symptoms, and consult your physician for any adverse signs